Tags: it for life sciences
Financial results for Q1 2021 just released: Group revenue up 1.2%
In Q1, we experienced continued strong growth within the International Life Sciences business, with Excellis performing to plan. Our Private & Public business started to see positive momentum in relation to the Winning Solutions strategy, which now constitutes 49% of NNIT’s revenue.
Lonza and NNIT partner to speed up MES projects
Across the life sciences industry, pharma companies are seeking new ways to respond to the high agility required to produce complex products like personalized cancer treatment, cell and gene therapy and Covid-19 vaccines. Central to these efforts is the manufacturing execution system (MES), which allows pharma companies to adopt pharma 4.0 production and manage their data flows to expedite product
NNIT to support COVID-19 vaccine safety data capture
NNIT, a trusted partner of AstraZeneca’s since 2014, will be implementing the critical COVID-19 vaccine post-marketing safety data system.
Acquisition-boosted Orifarm selects NNIT as new strategic IT partner
Orifarm and NNIT have signed a contract for the delivery of end-to-end IT services in connection with Orifarm’s acquisition of a significant portfolio of select over-the-counter (OTC) and prescription pharmaceutical products from Japanese pharmaceutical giant Takeda.
NNIT signs largest Veeva deal to date
NNIT recently signed its largest Veeva deal to date with a global top-10 life sciences company.
An expert in transition and transformation
NNIT’s new CFO, Pernille Fabricius, is a change management enthusiast: “I welcome and embrace change, and I enjoy leading an organization through a transformation process to stimulate growth and lasting value across the board. That’s what I’ve been doing throughout my career, and it’s what motivates me”.
NNIT and BA Insight partner to accelerate clinical trials
NNIT and BA Insight enters new partnership
NNIT Group acquires Excellis Health Solutions and continues its Life Sciences growth journey
NNIT acquires US-based Excellis, a leading specialized global provider in end-to-end supply chain consulting services to the life sciences industry.
Introducing NNIT Singapore
Following the acquisition of HGP in April 2019 and due legal processes, HGP’s Asia branch recently became NNIT Singapore Pte Ltd.
NNIT and Association of Danish Pharmacies extend collaboration
NNIT extends twelve-year collaboration another four years.
NNIT helps Life Science companies in the United States
NNIT is ready to help Life Science companies in the United States overcome the challenges they are facing.
New cool Cloud service from NNIT
New cool Cloud service from NNIT A/S that will benefit all Life Sciences companies. Life Sciences is our DNA: http://bit.ly/2fF0qfR
Have you initiated the IDMP readiness phase?
Pharmaceutical companies will soon be required to submit data in accordance to the ISO IDMP standard in the EU region.Have you initiated the #IDMP readiness phase? Be ready and read more here.
NNIT Announces Partnership with SAP to collaborate on IDMP
NNIT collaborates with SAP to deliver leading IT software and services for identification of medicinal products (IDMP) tailored to improve the reporting and tracking of product safety.
NNIT appoints new General Manager in North America to further boost its life sciences business
NNIT today announced the appointment of Jan Weber as General Manager of its North American affiliate. In this role, Jan Weber will lead NNIT’s consolidation as a leading provider of IT services and consultancy for the life sciences sector.
NNIT and SAS Institute enters strategic collaboration on ISO IDMP
Right now, Danish and European pharmaceutical companies are gearing up to comply with the ISO standards – designated IDMP – that come into force in the EU on 1 July 2016. The ISO IDMP standards require information from many areas of the pharmaceutical business, including regulatory affairs, research and development, manufacturing and distribution.
Are you ready for ISO IDMP?
Following the implementation of XEVMPD, new legislation, based on five new ISO IDMP standards, is due to come into force in 2016. Rune Ringsholm Bergendorff, advanced business consultant at NNIT, explains how pharmaceutical companies will need to adapt business processes across the whole organisation.